McGinley Orthopaedic Innovations, Inc. (“McGinley Orthopedics”), a leader in the development of innovative orthopedic surgical tools and technologies, announced today that it has been issued 8 additional patents by the United States Patent and Trademark Office (USPTO).
McGinley Orthopaedic Innovations, Inc. (“McGinley Orthopedics”), a leader in the development of innovative orthopedic surgical tools and technologies, announced today that it has been issued 8 additional patents by the United States Patent and Trademark Office (USPTO). This brings the company's total number of issued and pending patents to 127 across 71 patent families. The announcement further solidifies its position as a pioneer in using technology to deliver a better standard of orthopedic care.
"We are thrilled to have received these 8 additional patents," said Dr. Joseph McGinley, CEO of McGinley Orthopedics. "They represent the hard work and dedication of our engineering team, who look toward innovation to improve the lives of patients suffering from common breaks and fractures. Our in-house research and development efforts continue to break the norms for orthopedic surgical tools."
The continued corporate innovation is not limited to products either. The company is also pioneering how they finance their growth, offering a unique investment opportunity through its current Regulation A+ crowdfunding campaign. Anyone can invest in the company, regardless of income or net worth, and be a part of its growth and success. This is a rare opportunity for individual retail investors to get in on the ground floor of a private, rapidly growing company with a $6 Billion market opportunity.
"We are excited to offer this investment opportunity to the public. Our neighbors in Wyoming and people in towns across the country deserve access to invest in private companies. We want to provide a chance for all investors to improve the lives of patients and be part of our growth stage. That access should not be limited to Venture Capitalists and Private Equity firms" said Dr. McGinley.
The company's patent portfolio covers a wide range of orthopedic technologies. You can see the portfolio in action through 5 in-market FDA cleared products including the IntelliSense Drill Technology®, which puts precision in the hands of surgeons while repairing common bones fractures through depth measurement, edge detection, integrated lighting and more. Products like the IntelliSense® Drill are designed to improve patients outcomes, reduce costly errors, and save valuable operating room time. This innovative product can potentially save hospitals $1,850 per surgery.
"With more than 1000 surgeries completed to date, we are proud of the impact our products have had on the lives of patients. We are just at the beginning and the new patents will help us further our mission," said Dr. McGinley.
For more information about McGinley Orthopedics and its products, please visit the company's website at https://www.mcginleyorthopedicinnovations.com/
For more information, please contact:
Xerina Kahler McGinley Orthopedics 307.315.6403 firstname.lastname@example.org
Name: Xerina Kahler
Email: Send Email
Organization: McGinley Orthopedics
Address: 234 E 1st Street, Ste 242, Casper, WY 82601, United States
Release ID: 89089001
If you detect any issues, problems, or errors in this press release content, kindly contact email@example.com to notify us. We will respond and rectify the situation in the next 8 hours.